Genmab is an international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer.

InvestorPortal

To register your email address for electronic shareholder communications or to update your settings, log on to the InvestorPortal


Download Library

Access Genmab's financial reports, webcasts, presentations and more from the Download Library


 

5 Dec 150x110ASH 2016 Data Review Meeting

Genmab hosted an ASH 2016 Data Review Meeting on December 5 in San Diego, CA.The meeting included the presentation of daratumumab data presented at the 2016 American Society of Hematology Annual Meeting (December 3-6).The event was also be webcast and an archive of the webcast is available here.  To download the slides of the presentation, click hereThis meeting was NOT an official program of the ASH Annual Meeting.